← Leaderboards
Michael Glenn Ross
La Biomed Res Inst/ Harbor Ucla Med Ctr
$10,022,584
Attributed
$11,500,038
Total exposure
35
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,500,038 · 35
By mechanism
R01$7,926,871 · 5
M01$2,461,961 · 22
R21$788,154 · 2
R03$278,052 · 2
R13$45,000 · 4
Top collaborators
- Mina Desai12 shared
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Mina Desai$3,785,165
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAmniotic FluidHuman SubjectHuman Pregnant SubjectFemalePlasmaFetalPregnancy DisorderHuman Therapy EvaluationLifeProgramsNeuronsOffspringSheepObesityBirthHomeostasisEmbryo /FetusPregnancyArginine VasopressinOsmotic PressurePreventSwallowingAdult
Grant awards (90)
Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity$515,752
R01 · FY2023 · HD · contact PI
Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity$517,655
R01 · FY2022 · HD · contact PI
Prevention of obesity in Infants of overweight and obese women$192,625
R21 · FY2022 · HD · contact PI
Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity$517,295
R01 · FY2021 · HD · contact PI
Prevention of obesity in Infants of overweight and obese women$231,150
R21 · FY2021 · HD · contact PI
US DOHaD Society: The 5th Annual Meeting 2020$13,000
R13 · FY2021 · ES
Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity$571,053
R01 · FY2020 · HD · contact PI
US DOHaD 2019: The 4th Annual Meeting$10,000
R13 · FY2019 · ES
US DOHaD 2018: The 3rd Annual Meeting$10,000
R13 · FY2018 · ES
Developmental origins of health and disease$12,000
R13 · FY2017 · ES
Developmentally Programmed Hyperphagia and Obesity via BPA enhanced Neurogenesis$168,837
R21 · FY2014 · ES · contact PI
Developmentally Programmed Hyperphagia and Obesity via BPA enhanced Neurogenesis$195,542
R21 · FY2013 · ES · contact PI
Mechanisms of Programmed Gestational Hyperphagia$286,288
R01 · FY2012 · HD · contact PI
Mechanisms of Programmed Gestational Hyperphagia$283,832
R01 · FY2011 · HD · contact PI
Mechanisms of Programmed Gestational Hyperphagia$293,175
R01 · FY2010 · HD · contact PI
Mechanisms of Programmed Gestational Hyperphagia$293,700
R01 · FY2009 · HD · contact PI
Mechanisms of Programmed Gestational Hyperphagia$291,334
R01 · FY2008 · HD · contact PI
DO IONIZED MAGNESIUM LEVELS PREDICT CLINICAL EFFECTS BETTER THAN TOTAL MAGNESIS$2,631
M01 · FY2008 · RR · contact PI
AQUAPORIN GENE EXPRESSION IN HUMAN FETAL MEMBRANE$548
M01 · FY2008 · RR · contact PI
Fetal Swallowing: Central Dipsogenic Mechanisms$340,768
R01 · FY2007 · DK · contact PI
DO IONIZED MAGNESIUM LEVELS PREDICT CLINICAL EFFECTS BETTER THAN TOTAL MAGNESIS$4,375
M01 · FY2007 · RR · contact PI
AQUAPORIN GENE EXPRESSION IN HUMAN FETAL MEMBRANE$1,297
M01 · FY2007 · RR · contact PI
Fetal Swallowing: Central Dipsogenic Mechanisms$292,330
R01 · FY2006 · DK · contact PI
Fetal Swallowing: Central Dipsogenic Mechanisms$52,306
R01 · FY2006 · DK · contact PI
AQUAPORIN GENE EXPRESSION IN HUMAN FETAL MEMBRANE$3,927
M01 · FY2006 · RR · contact PI
THE COMPARISON OF PLACENTAL AND UMBILICAL NUCLEATED RED BLOOD CELL COUNT$374
M01 · FY2006 · RR · contact PI
Fetal Swallowing: Central Dipsogenic Mechanisms$295,956
R01 · FY2005 · DK
THE COMPARISON OF PLACENTAL AND UMBILICAL NUCLEATED RED BLOOD CELL COUNT$21,562
M01 · FY2005 · RR
AQUAPORIN GENE EXPRESSION IN HUMAN FETAL MEMBRANE$10,592
M01 · FY2005 · RR
Fetal Swallowing: Central Dipsogenic Mechanisms$292,679
R01 · FY2004 · DK
Fetal Swallowing: Central Dipsogenic Mechanisms$146,744
R01 · FY2004 · DK
Fetal Swallowing: Central Dipsogenic Mechanisms$142,762
R01 · FY2004 · DK
Fetal Membrane AQP Expression/Amniotic Fluid Regulation$62,372
R03 · FY2004 · HD
Comparison of Placental and Umbilical Nucleated Red$17,427
M01 · FY2004 · RR
Osmoregulation in Postpartum Women and Newborn Infants$5,199
M01 · FY2004 · RR
Aquaporin Gene Expression in Human Fetal Membrane$2,696
M01 · FY2004 · RR
Fetal Urine Production&Swallowing Rate: Correlation with Amniotic Fluid Volume$1,733
M01 · FY2004 · RR
Fetal Swallowing: Central Dipsogenic Mechanisms$335,877
R01 · FY2003 · DK
Fetal Membrane AQP Expression/Amniotic Fluid Regulation$62,372
R03 · FY2003 · HD
MATERNAL DEHYDRATION--FETAL/AMNIOTIC FLUID HOMEOSTASIS$362,321
R01 · FY2002 · HL
FETAL SWALLOWING--CENTRAL DIPSOGENIC MECHANISMS$268,903
R01 · FY2002 · DK
FETAL SWALLOWING--CENTRAL DIPSOGENIC MECHANISMS$131,746
R01 · FY2002 · DK
FETAL SWALLOWING--CENTRAL DIPSOGENIC MECHANISMS$78,950
R01 · FY2002 · DK
LEPTIN &NEUROPEPTIDE-Y ALTERS FETAL SWALLOWING ACTIVITY$76,654
R03 · FY2002 · HD
MATERNAL DEHYDRATION--FETAL/AMNIOTIC FLUID HOMEOSTASIS$353,184
R01 · FY2001 · HL
FETAL SWALLOWING--CENTRAL DIPSOGENIC MECHANISMS$261,072
R01 · FY2001 · DK
NOVEL ESTROGEN STIMULATED MATERIAL (OXYTOCIN GLYCINE) IN HUMAN PLASMA$237,978
M01 · FY2001 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS$237,978
M01 · FY2001 · RR
AMINOINFUSION WITH ANTIBIOTIC ON INCIDENCE OF MATERNAL CHORIOAMNIONI$237,978
M01 · FY2001 · RR
NOVEL METHOD FOR AMNIOTIC FLUID CALCULATION$237,978
M01 · FY2001 · RR
GENTAMICIN/CLINDAMYCIN IN PREVENTION OF POSTPARTUM ENDOMYOMETRITIS$237,978
M01 · FY2001 · RR
DOUBLE LUMEN, UTERINE CATHETER FOR AMNIOINFUSION$237,978
M01 · FY2001 · RR
AMNIOINFUSION FOR FAILED VERSION OF BREECH PRESENTATION$237,978
M01 · FY2001 · RR
PREVENTION &TREATMENT OF HUMAN OLIGOHYDRAMNIOS$237,978
M01 · FY2001 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS IN PRETERM PREMATURE$237,978
M01 · FY2001 · RR
OSMOREGULATION IN POSTPARTUM WOMEN &NEWBORN INFANTS$237,978
M01 · FY2001 · RR
PREVENTION AND TREATMENT OF HUMAN OLIGOHYDRAMNIOS$203,817
R01 · FY2001 · HD
LEPTIN &NEUROPEPTIDE-Y ALTERS FETAL SWALLOWING ACTIVITY$76,654
R03 · FY2001 · HD
FETAL SWALLOWING--CENTRAL DIPSOGENIC MECHANISMS$253,470
R01 · FY2000 · DK
MATERNAL DEHYDRATION--FETAL/AMNIOTIC FLUID HOMEOSTASIS$211,384
R01 · FY2000 · HL
PREVENTION AND TREATMENT OF HUMAN OLIGOHYDRAMNIOS$199,594
R01 · FY2000 · HD
MATERNAL DEHYDRATION--FETAL/AMNIOTIC FLUID HOMEOSTASIS$132,924
R01 · FY2000 · HL
PREVENTION &TREATMENT OF HUMAN OLIGOHYDRAMNIOS$982
M01 · FY2000 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS$982
M01 · FY2000 · RR
OSMOREGULATION IN POSTPARTUM WOMEN &NEWBORN INFANTS$982
M01 · FY2000 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS IN PRETERM PREMATURE$982
M01 · FY2000 · RR
AMNIOINFUSION FOR FAILED VERSION OF BREECH PRESENTATION$982
M01 · FY2000 · RR
DOUBLE LUMEN, UTERINE CATHETER FOR AMNIOINFUSION$982
M01 · FY2000 · RR
GENTAMICIN/CLINDAMYCIN IN PREVENTION OF POSTPARTUM ENDOMYOMETRITIS$982
M01 · FY2000 · RR
NOVEL METHOD FOR AMNIOTIC FLUID CALCULATION$982
M01 · FY2000 · RR
NOVEL ESTROGEN STIMULATED MATERIAL (OXYTOCIN GLYCINE) IN HUMAN PLASMA$982
M01 · FY2000 · RR
AMINOINFUSION WITH ANTIBIOTIC ON INCIDENCE OF MATERNAL CHORIOAMNIONI$982
M01 · FY2000 · RR
NOVEL ESTROGEN STIMULATED MATERIAL (OXYTOCIN GLYCINE) IN HUMAN PLASMA$0
M01 · FY2000 · RR
Prevention and treatment of human oligohydromnios$0
M01 · FY2000 · RR
NOVEL ESTROGEN STIMULATED MATERIAL (OXYTOCIN GLYCINE) IN HUMAN PLASMA$0
M01 · FY2000 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS$0
M01 · FY2000 · RR
DOUBLE LUMEN, UTERINE CATHETER FOR AMNIOINFUSION$0
M01 · FY2000 · RR
DOUBLE LUMEN, UTERINE CATHETER FOR AMNIOINFUSION$0
M01 · FY2000 · RR
AMINOINFUSION WITH ANTIBIOTIC ON INCIDENCE OF MATERNAL CHORIOAMNIONI$0
M01 · FY2000 · RR
NOVEL METHOD FOR AMNIOTIC FLUID CALCULATION$0
M01 · FY2000 · RR
NOVEL METHOD FOR AMNIOTIC FLUID CALCULATION$0
M01 · FY2000 · RR
AMINOINFUSION WITH ANTIBIOTIC ON INCIDENCE OF MATERNAL CHORIOAMNIONI$0
M01 · FY2000 · RR
Prevention and treatment of human oligohydromnios$0
M01 · FY2000 · RR
Prevention and treatment of human oligohydromnios$0
M01 · FY2000 · RR
Prevention and treatement of human oligohydramnios$0
M01 · FY2000 · RR
Prevention and treatement of human oligohydramnios$0
M01 · FY2000 · RR
Prevention and treatement of human oligohydramnios$0
M01 · FY2000 · RR
MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS$0
M01 · FY2000 · RR
OSMOREGULATION IN POSTPARTUM WOMEN &NEWBORN INFANTS$0
M01 · FY2000 · RR
OSMOREGULATION IN POSTPARTUM WOMEN &NEWBORN INFANTS$0
M01 · FY2000 · RR